Spots Global Cancer Trial Database for gastroenteropancreatic neuroendocrine tumor g3
Every month we try and update this database with for gastroenteropancreatic neuroendocrine tumor g3 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 | NCT03457844 | Gastroenteropan... | Anlotinib | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 | NCT03457844 | Gastroenteropan... | Anlotinib | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
